Kominami S, Nishida N, Takemori S
Faculty of Integrated Arts and Sciences, Hiroshima University, Japan.
Biochim Biophys Acta. 1996 Jun 11;1301(3):199-206. doi: 10.1016/0005-2760(96)00033-1.
A steroidogenic pathway from cholesterol to aldosterone was reconstituted in liposome membranes using cytochromes P-450scc, P-450C21 and P-450(11) beta, and 3 beta-hydroxysteroid dehydrogenase/ delta 5-delta 4 isomerase (3 beta HSD/I) with their electron transfer systems. All of the enzymes were purified from bovine adrenocortical mitochondria and microsomes. The cholesterol metabolism in the liposomal reconstituted system was compared with that in the combined organella system composed of bovine adrenocortical mitochondria and microsomes, where the activity of P-450(17) alpha,lyase was inhibited by bifonazole. The metabolic activities in these two systems were similar except for aldosterone production. Aldosterone was produced in the liposomal system but not in the combined organella system. 4-fold increase in the amount of P-450scc in the liposomal system enhanced the activity of 3 beta HSD/I, P-450C21 and 11 beta-hydroxylase of P-450(11) beta but decreased 18-hydroxycorticosterone and aldosterone production by P-450(11) beta, supporting our previous findings describing the regulation mechanism of aldosterone synthesis (Kominami, S., Harada, D. and Takemori, S. (1994) Biochim. Biophys. Acta 1192, 234). It was demonstrated using the liposomal reconstituted system that the increase in the amount of one enzyme did not only increase the metabolizing activity of that enzyme but also affect other enzyme in various ways.
利用细胞色素P-450scc、P-450C21、P-450(11)β以及3β-羟基类固醇脱氢酶/δ5-δ4异构酶(3βHSD/I)及其电子传递系统,在脂质体膜中重建了一条从胆固醇到醛固酮的类固醇生成途径。所有这些酶均从牛肾上腺皮质线粒体和微粒体中纯化得到。将脂质体重组系统中的胆固醇代谢与由牛肾上腺皮质线粒体和微粒体组成的联合细胞器系统中的胆固醇代谢进行了比较,在联合细胞器系统中,联苯苄唑抑制了P-450(17)α裂解酶的活性。除醛固酮生成外,这两个系统中的代谢活性相似。醛固酮在脂质体系统中产生,但在联合细胞器系统中不产生。脂质体系统中P-450scc量增加4倍增强了3βHSD/I、P-450C21和P-450(11)β的11β-羟化酶的活性,但降低了P-450(11)β产生的18-羟皮质酮和醛固酮,这支持了我们之前描述醛固酮合成调节机制的研究结果(小见南史、原田敦、武居史郎(1994年)《生物化学与生物物理学学报》1192,234)。利用脂质体重组系统证明,一种酶量的增加不仅会增加该酶的代谢活性,还会以各种方式影响其他酶。